IPO

Quest Laboratories Limited IPO

NSE SME

Listed On: May 23, 2024 at ₹ 155.1

₹ 232800 /2400 Shares
*Min Investment

Check Allotment

15 May, 2024

Open Date

17 May, 2024

Close Date

21 May, 2024

Allotment Date

23 May, 2024

Listing Date
Quest Laboratories Limited IPO Issue Details
  • Issue Price ₹93-97 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 44,49,600 shares(aggregating up to ₹43.16 crore)
  • Fresh Share 44,49,600 shares(aggregating up to ₹43.16 crore)
  • Listing at NSE SME
  • List Price 155.1
  • Listing Date 2024-05-23
  • Lead Manager Shreni Shares Limited
  • Registrar Bigshare Services Pvt Ltd
Market Lot Size

Investors can bid for a minimum of 1200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (min)11200₹1,16,400
Retail(max)11200₹1,16,400
NII (min) 22,400₹2,32,800
Quest Laboratories Limited IPO Reservation

Quest Laboratories Limited IPO offers total 4,449,600 shares. Out of which 831,600 (18.69%) allocated to QIB, 655,200 (14.72%) allocated to NII,1,498,800 (33.68%) allocated to RII, NA (NA%) allocated to employees and 1,236,000 (27.78%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares Offered1,236,000 (27.78%)
Market Maker Shares Offered228,000 (5.12%)
QIB Shares Offered831,600 (18.69%)
NII (HNI) Shares Offered655,200 (14.72%)
Retail Shares Offered1,498,800 (33.68%)
Total Shares Offered4,449,600 (100%)
Quest Laboratories Limited IPO Documents
DRHP
RHP
Quest Laboratories Limited IPO Details


Quest Laboratories Limited IPO is an SME IPO, priced at ₹93-97 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 44,49,600 equity shares, aggregating up to ₹43.16 crores..

The IPO bidding window is open from May 15, 2024 to May 17, 2024. The allotment is expected to be finalized on May 21, 2024, and the tentative listing date is May 23, 2024.

The minimum lot size for Retail investors is 1200 shares, with a minimum investment of ₹1,16,400. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,32,800.

Shreni Shares Limited is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and Rikhav Securities Limited will act as the market maker for this issue.

Read More
Quest Laboratories Limited IPO Subscription Analysis And Details
Retail
57.63x
Total
85.26x
As onQIB / NIIRetailTotal
Shares Offered / Reserved831,600 / 655,2001,498,8002,985,600
Day 1 15-05-24 06:00 PM
0.01 / 0.76 x2.17 x1.26 x
Day 2 16-05-24 06:00 PM
0.01 / 2.39 x6.34 x3.71 x
Day 3 17-05-24 06:00 PM
57.20 / 184.10 x57.63 x85.26 x
Total No of Applications
71,975
Quest Laboratories Limited Valuations
EPS Pre IPO ₹4.21/-
EPS Post IPO ₹6.31/-
P/E Pre IPO 23.03
P/E Post IPO 15.38
ROE 34.03%
ROCE 41.86%
Debt/Equity 0.20
RoNW 34.03%
PAT Margin 12.48
Price to Book Value 4.59
Quest Laboratories Limited Company Financials
In Lakhs
In Lakh
31-Mar-2331-Mar-2231-Mar-21
Assets4,664.723,479.861,839.63
Revenue6,186.605,954.203,043.55
Profit After Tax502.85410.5065.50
Net Worth1,502.21999.38588.84
Reserves & Surplus1,394.33891.50480.96
Total Borrowing409.69312.54304.03
About Quest Laboratories Limited Company

Incorporated in June 1998, Quest Laboratories Limited is a pharmaceutical company that manufactures a wide range of antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory drugs, diabetes, antidepressants, and more.

The company caters to the domestic market of twelve (12) states and two (2) union territories. These are Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana, and Bihar.

The manufacturing unit of the company is situated in Dhar, Madhya Pradesh.

The company is holding WHO Schedule M GMP and GLP accreditations and ISO/IEC 17025:2017 and ISO 9001:2015 accreditations.

As on 31st December 2023, the company will have 83 employees to take care of all the different functions of its manufacturing process from production, quality control, technical and engineering support services, inventory management, administration, account, and other storehouse and packing and dispatch.

Read More
Quest Laboratories Limited - Promoter(s)

Mr. Anil Kumar Sabarwal

Ms. Tejaswini Sabarwal

Pre Issue Share Holding : 90.36%

Post Issue Share Holding : 65.82%

Quest Laboratories Limited IPO - Issue Objectives
1

Funding of capital expenditure towards purchase of plant and machinery for expansion at the existing manufacturing facility

2

Funding working capital requirements of the company

3

General corporate purposes;

Quest Laboratories Limited IPO - Peers Comparison
Company NameEPS (Basic)EPS (Diluted)NAV (per share) (Rs)P/E (x)RoNW (%)P/BV RatioFinancial statements
Quest Laboratories Limited4.664.6613.93N/A33.47N/AStandalone
Beta Drugs Limited19.5719.57100.1266.4319.5512.98Standalone
Alpa Laboratories Ltd.5.95.968.6915.928.591.37Standalone
Zenith Drugs Limited4.294.2914.3714.6929.884.38Consolidated

Notes:

  1. The figures for the company are based on Restated Financial Statements for the year ended March 31, 2023 after considering the bonus issue.
  2. The figures for the Peer Group are based on the Standalone Financial Statements filed for the financial year ended March 31, 2023, except for Zenith Drugs Limited, which is based on Consolidated Financial Statements.
  3. The P/E Ratio has been computed based on their respective closing market price on May 06, 2024, divided by the Basic EPS as on March 31, 2023.
Contact Details

Quest Laboratories Limited

Plot No. 45, Sector III, Pithampur Industrial Area, Pithampur, Dhar - 454775

07292292374

investors@questlabltd.com

https://www.questlabltd.com/

Registrar Contact Details

Bigshare Services Pvt Ltd

+91-22-6263 8200

ipo@bigshareonline.com

https://ipo.bigshareonline.com/ipo_status.html